Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site

Changhong Li, Ming Li, Pan Chen, Srinivas Narayan, Franz M. Matschinsky, Michael J. Bennett, Charles A. Stanley, Thomas Smith

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/ hyperammonemia syndrome (HHS), resulting in increased pancreatic β-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals.Wehave previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in theHHSmouse model is improved upon chronic administration of EGCG. These results suggest that thiscommonnaturalproductorsomederivativethereofmayprove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via theseGDHinhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.

Original languageEnglish (US)
Pages (from-to)34164-34174
Number of pages11
JournalJournal of Biological Chemistry
Volume286
Issue number39
DOIs
StatePublished - Oct 30 2011
Externally publishedYes

Fingerprint

Glutamate Dehydrogenase
Polyphenols
Tea
Adenosine Diphosphate
Transgenic Mice
Chemical activation
Glutamine
Allosteric Site
Mutagenesis
Deamination
Inborn Genetic Diseases
Metabolites
Site-Directed Mutagenesis
Guanosine Triphosphate
Islets of Langerhans
Hypoglycemia
Leucine
Oral Administration
Meals
Blood Glucose

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site. / Li, Changhong; Li, Ming; Chen, Pan; Narayan, Srinivas; Matschinsky, Franz M.; Bennett, Michael J.; Stanley, Charles A.; Smith, Thomas.

In: Journal of Biological Chemistry, Vol. 286, No. 39, 30.10.2011, p. 34164-34174.

Research output: Contribution to journalArticle

Li, Changhong ; Li, Ming ; Chen, Pan ; Narayan, Srinivas ; Matschinsky, Franz M. ; Bennett, Michael J. ; Stanley, Charles A. ; Smith, Thomas. / Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 39. pp. 34164-34174.
@article{34ceb3220292429db0ac5dab17d7d265,
title = "Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site",
abstract = "Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/ hyperammonemia syndrome (HHS), resulting in increased pancreatic β-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals.Wehave previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in theHHSmouse model is improved upon chronic administration of EGCG. These results suggest that thiscommonnaturalproductorsomederivativethereofmayprove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via theseGDHinhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.",
author = "Changhong Li and Ming Li and Pan Chen and Srinivas Narayan and Matschinsky, {Franz M.} and Bennett, {Michael J.} and Stanley, {Charles A.} and Thomas Smith",
year = "2011",
month = "10",
day = "30",
doi = "10.1074/jbc.M111.268599",
language = "English (US)",
volume = "286",
pages = "34164--34174",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "39",

}

TY - JOUR

T1 - Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site

AU - Li, Changhong

AU - Li, Ming

AU - Chen, Pan

AU - Narayan, Srinivas

AU - Matschinsky, Franz M.

AU - Bennett, Michael J.

AU - Stanley, Charles A.

AU - Smith, Thomas

PY - 2011/10/30

Y1 - 2011/10/30

N2 - Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/ hyperammonemia syndrome (HHS), resulting in increased pancreatic β-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals.Wehave previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in theHHSmouse model is improved upon chronic administration of EGCG. These results suggest that thiscommonnaturalproductorsomederivativethereofmayprove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via theseGDHinhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.

AB - Glutamate dehydrogenase (GDH) catalyzes the oxidative deamination of L-glutamate and, in animals, is extensively regulated by a number of metabolites. Gain of function mutations in GDH that abrogate GTP inhibition cause the hyperinsulinism/ hyperammonemia syndrome (HHS), resulting in increased pancreatic β-cell responsiveness to leucine and susceptibility to hypoglycemia following high protein meals.Wehave previously shown that two of the polyphenols from green tea (epigallocatechin gallate (EGCG) and epicatechin gallate (ECG)) inhibit GDH in vitro and that EGCG blocks GDH-mediated insulin secretion in wild type rat islets. Using structural and site-directed mutagenesis studies, we demonstrate that ECG binds to the same site as the allosteric regulator, ADP. Perifusion assays using pancreatic islets from transgenic mice expressing a human HHS form of GDH demonstrate that the hyperresponse to glutamine caused by dysregulated GDH is blocked by the addition of EGCG. As observed in HHS patients, these transgenic mice are hypersensitive to amino acid feeding, and this is abrogated by oral administration of EGCG prior to challenge. Finally, the low basal blood glucose level in theHHSmouse model is improved upon chronic administration of EGCG. These results suggest that thiscommonnaturalproductorsomederivativethereofmayprove useful in controlling this genetic disorder. Of broader clinical implication is that other groups have shown that restriction of glutamine catabolism via theseGDHinhibitors can be useful in treating various tumors. This HHS transgenic mouse model offers a highly useful means to test these agents in vivo.

UR - http://www.scopus.com/inward/record.url?scp=80053193812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053193812&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.268599

DO - 10.1074/jbc.M111.268599

M3 - Article

VL - 286

SP - 34164

EP - 34174

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 39

ER -